Surgical Innovations Investors - SUN

Surgical Innovations Investors - SUN

Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
Monthly Subscription
for only
UK/US Silver
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type
Surgical Innovations Group Plc SUN London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 2.70 08:00:00
Open Price Low Price High Price Close Price Previous Close
2.70 2.70 2.70 2.70 2.70
more quote information »
Industry Sector

Top Investor Posts

jmf69: There was a question in the investor presentation about how much revenue for each of the 3 hospitals currently converted in the UK. The answer was obviously depending on which instruments they take but for a typical lap cholecystectomy would be about 1000 procedures annually with each lap cholecystectomy kit costing £100. The answer was given as £10k plus other items added in leading to £25k to £30k.For anyone with a gcse in maths 100 × 1000 =100000 = 100k.So each hospital would be 100k for the lap cholecystectomy kits over the year and not 10k as answered. I was just listening to the q&a section again. Gla.
jmf69: and Q&A now available to view.If the vaccine rollout continues at pace and is effective then I believe we are in for a good year. Gla.
jmf69: I thought it was a very useful and informative investor meeting. Happy to hold for now with things looking up particularly with increasing access to the USA market.
gnnmartin: I did not know there is to be an investor presentation, can you give details, please? I can't find it in the results RNS.
jmf69: Agreed. Results seem ok given the covid-19 impact. We knew revenue was going to be down and importantly the current year is ahead 11% compared to last year before covid-19 hit major markets.Topped up 200k this morning and given the vaccine rollout and return of elective surgery, we should see a major recovery this year. Not to mention the new contracts in the USA. Anyone attending the investor presentation this afternoon?
buywell3: The list of Institutional Investors in SUN reads better than some FTSE100 stocks The percentage of SUN that is owned by these larger Investors is now very large So getting shares for the PI in any quantity is not too good and as better news of Distribution deals comes that gets harder still eg expect news re Dexter and other Robotics soon The market in the USA for Fix8 in 2023 will imo earn SUN about $1M Which means according to my maths === see previous posts re Trocar sales and SUN surgical instrument sales with USA Distributors Microline and Alder ( both 5yr deals) Means SUN should in buywells opine be turning over circa $6M plus from the USA alone in 2023 That is without new products which will be coming to market over the next 12 months -- Trocars and others This stock has only just started to play catch up imo That AMS has not moved to acquire it at these levels has surprised buywell , when Fix8 has FDA approval in 2022 --- then the Mkt Cap of SUN should have risen a fair bit higher than it is today dyor
jmf69: Results and investor presentation on 25th March
buywell3: To any newbe to SUN A couple of points to think about from here on 1) Planned operations in the NHS have been getting cancelled for the last few years around the winter flu season when beds get full in hospitals. This has been made worse by Covid-19 and looks now imo to be an ongoing issue for the NHS and Government to sort out . 2) Cancellation of operations does NOT however mean that the work is lost unless of course the patient dies --- which regards to MIS the area of SUN operations is imo unlikely in the vast majority of cases so what it means is that the backlog of work stacks up It is fairly obvious now that there is a bed shortage in ICU's and also a staff shortage Ditto for nurses across other wards Not enough doctors, surgeons or Hospitals to cope with what will be the Covid endemic as we all learn to live a vaccine existance getting what imo will be at least 2 Covid-19 jabs a year until a cure is found . So the Government has to invest in technologies that can clear the backlog and keep pace with increase in work as more sick patients arrive at Hospitals MIS reduces LOS in Hospitals so it frees up beds and allows more patients to receive treatment MIS results in less complications after surgery so it saves money re claims and is better in patient outcomes a win/win MIS Robotic surgery has the potential to increase the output of operations carried out as robots do not get tired or go sick or take annual leave buywell expects to see a RNS from SUN very soon now to say that a certain Hospital/s with NHS Trust XXXX has leased yyy Dexters buywell expects such an RNS to be accompanied by investors buying SUN as such news sinks in buywell expects further RNS's to follow as other Hospitals and other NHS Trusts follow with a similar result
xylemflow: The spread is so wide because there just isn't much in the market - sellers think its got a lot more life in it and buyers are after a bargain. It is the circular problem of AIM lack of liquidity. Big spreads make a share illiquid, and illiquid shares have a big spread. Catch 22. At the moment, all of the trades are small. It needs a big investor to take a view on the future of this share and to hoover-up a load regardless of price (to a point). Once that happens there will be a lot of smaller shareholders keen to sell, creating a more liquid market at a higher price.... at least that is what I learned at business school!!
ADVFN Advertorial
Your Recent History
Surgical I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210804 02:07:23